We are very happy to attend the 2nd Next-Generation Conjugates Summit of Boston 2023, organized by Hanson Wade from 21st to 23rd of February.
The focus of this Summit is working on the progressing the Future of Bioconjugate, pushing the Boundaries of these Drug Development With Next-Generation Payloads & Formats to Improve Translation & Show Clinical Proof-of-Concept.
As next-generation conjugates begin to take their place centre stage within the bioconjugate world, the 2nd Next-Generation Conjugates Summit is the only event dedicated to showcasing out-of-the-box technologies and approaches to designing next-generation conjugates, overcoming key translational challenges, as well as addressing key regulatory and manufacturing challenges.
The Summit offers the opportunity to be part of exclusive discussions on expanding the application of conjugate drugs.
During the Summit, the attendees will learn how to overcome key translational challenges including model selection and regulatory guidance, as well as addressing important downstream manufacturing and scale-up challenges.
BSP's team looks forward to meeting You at our booth in the exibithor area
To request a meeting, please send an e-mail to Business.Development@Bsppharmaceuticals.com
Save the Date!!! Next Thursday, 23rd February 2023, our Giorgio Salciarini (Marketing & Business Development Manager), will presents to other guests its speech 'Looking to satisfy the growing demand of capacity and capabilities for ADCs' during the Conference Day2, from 08:45 AM.